IMC Chicago LLC Invests $1.55 Million in iShares Biotechnology ETF $IBB

IMC Chicago LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,712 shares of the financial services provider’s stock, valued at approximately $1,546,000.

Several other hedge funds and other institutional investors have also recently bought and sold shares of IBB. Citigroup Inc. grew its stake in shares of iShares Biotechnology ETF by 27.0% during the 2nd quarter. Citigroup Inc. now owns 4,073,967 shares of the financial services provider’s stock worth $515,398,000 after purchasing an additional 865,823 shares during the period. JPMorgan Chase & Co. grew its position in shares of iShares Biotechnology ETF by 74.2% during the 2nd quarter. JPMorgan Chase & Co. now owns 833,196 shares of the financial services provider’s stock valued at $105,408,000 after acquiring an additional 355,000 shares during the period. Bronte Capital Management Pty Ltd. increased its stake in shares of iShares Biotechnology ETF by 12.6% in the 2nd quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock valued at $37,000 after purchasing an additional 32,947 shares in the last quarter. Employees Retirement System of Texas acquired a new position in iShares Biotechnology ETF in the 2nd quarter worth about $25,049,000. Finally, Thrivent Financial for Lutherans boosted its position in iShares Biotechnology ETF by 5.8% during the third quarter. Thrivent Financial for Lutherans now owns 111,863 shares of the financial services provider’s stock worth $16,149,000 after purchasing an additional 6,157 shares in the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $174.98 on Friday. iShares Biotechnology ETF has a 12 month low of $107.43 and a 12 month high of $179.64. The stock’s 50 day moving average is $171.53 and its two-hundred day moving average is $156.09.

iShares Biotechnology ETF Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, December 19th. Investors of record on Tuesday, December 16th were issued a $0.1831 dividend. This represents a $0.73 annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend was Tuesday, December 16th. This is a boost from iShares Biotechnology ETF’s previous quarterly dividend of $0.08.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.